Gut Microbiome Modification Through Dietary Intervention in Patients With Colorectal Cancer: Response to Surgery
NCT ID: NCT04869956
Last Updated: 2022-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2021-06-01
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be randomized in a 1:1 ratio after receiving a diagnosis of CRC in the endoscopic evaluation; in the control arm, patients will receive standard nutritional recommendations, while patients in the intervention arm will be advised to follow a high-fiber diet rich in PUFAs (total dietary intake of at least 30 grams of fiber per day, and of at least 3 grams of PUFAs per day from food, not supplements) at least 4 weeks before surgery
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery
NCT04005118
Gut Microbiota, Anastomotic Leak and Colorectal Cancer
NCT04071964
Gut Microbiota and Color-rectal Cancer.
NCT04662853
Modified MAC Diet and Gut Microbiota in CRC Patients
NCT05039060
Low-fiber Diet for Colorectal Cancer Screening Colonoscopy
NCT02401802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard diet
Dietary pattern: Standard diet
Dietary pattern: Standard diet
standard nutritional recommendations
High - Fiber diet rich in PUFA
High - Fiber diet rich in PUFA
Dietary pattern : High-fiber diet rich in PUFA
High-fiber diet rich in PUFAs (total dietary intake of at least 30 grams of fiber per day, and of at least 3 grams of PUFAs per day from food, not supplements) at least 4 weeks before surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary pattern : High-fiber diet rich in PUFA
High-fiber diet rich in PUFAs (total dietary intake of at least 30 grams of fiber per day, and of at least 3 grams of PUFAs per day from food, not supplements) at least 4 weeks before surgery
Dietary pattern: Standard diet
standard nutritional recommendations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* After clinical diagnosis of CRC (stage I-III), the doctor has recommended and arranged for CRC surgery
Exclusion Criteria
* Current gastrointestinal illness other than gastroesophageal reflux disease or hemorrhoids (such as celiac disease, inflammatory bowel disease, malabsorptive bariatric procedures, etc.).
* Chronic liver or kidney disease.
* History of cardiac disease.
* Positive genetic test for inherited polyposis syndromes (such as familial adenomatous polyps, hereditary non-polyposis colon cancer syndromes, etc).
* Alcoholism or illicit drug use.
* Antibiotic use within the past 2 months.
* Dietary supplement use including pre- or probiotics within the past month.
* History of intestinal cancer, inflammatory bowel disease, celiac disease, or malabsorptive bariatric surgery.
* Inflammatory or connective tissue disease (such as lupus, scleroderma, rheumatoid arthritis, etc.).
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biomedical Research Institute of Murcia (IMIB-Arrixaca)
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-2-7-HCUVA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.